Log in to search using one of your social media accounts:

 

Study examines use of systolic blood pressure at time of primary percutaneous coronary intervention
(Society for Cardiovascular Angiography and Interventions) Researchers have led a retrospective single-center study examining simple hemodynamic parameters obtained at the time of cardiac catheterization to predict in-hospital mortality following ST-elevation myocardial infarction (STEMI). Current 30-day mortality rates for patients with STEMI range from 2.5% to 10%, and 10.5%-24% of those patients require mechanical hemodynamic support. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 11, 2017 Category: International Medicine & Public Health Source Type: news

The use of computed tomographic angiography in the evaluation of upper digestive tract injuries in penetrating neck trauma - Maritz JPB, Lubbe JA.
BACKGROUND: Patients who present with penetrating neck injuries undergo both a computed tomographic angiogram (CTA) of the neck to diagnose vascular injuries and a contrasted swallow to diagnose aerodigestive tract injuries. In a resource constrained setti... (Source: SafetyLit)
Source: SafetyLit - September 8, 2017 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Siemens & #039; New Offering Could Give Heart Teams a Better View
As treatment options for structural heart disease continue to rapidly evolve, procedures increasingly involve multimodality imaging and multidisciplinary clinical teams. To reliably diagnose structural heart disease and perform these complex interventions, clinicians need detailed, real-time imaging information – such as real-time soft tissue and blood flow information from echocardiography as well as 2-D imaging information from fluoroscopy – to be visible in one view for common orientation. Siemens Healtineers has responded to that need with a new cardiovascular application designed to integrate ultrasound an...
Source: MDDI - September 8, 2017 Category: Medical Devices Authors: Amanda Pedersen Tags: Imaging Medical Device Business Source Type: news

Siemens launches TrueFusion1 cardiovascular ultrasound application
Siemens (NYSE:SI) Healthineers said today it launched the TrueFusion1 application for its Acuson SC2000 cardiovascular ultrasound system, designed to integrate ultrasound and angiography images to guide structural heart disease treatments. The TrueFusion application is designed to send anatomical and functional markers, in addition to valve models, from the Acuson SC2000’s true volume transesophageal echocardiography transducer to an Artis angiography system to overlay ultrasound with live fluoroscopy images. “With one of the industry’s broadest portfolios for diagnosis, therapy, and follow-up of car...
Source: Mass Device - September 6, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular Imaging Surgical Siemens Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 31, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. This exoskeleton could eliminate crouch gait The National Institutes of Health has created what it claims is the first robotic exoskeleton that is designed to treat crouch gait in children who have cerebral palsy. Crouch gait o...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

HeartFlow wins positive policy decisions from 3 BCBS providers
HeartFlow said today it won positive medical policies for its HeartFlow FFRct fractional flow reserve analysis system from 3 separate Blue Cross Blue Shield providers. The Redwood City, Calif.-based company said that Anthem Blue Cross Blue Shield, Blue Shield of California and Blue Cross and Blue Shield of Alabama issued positive medical policies supporting the use of the FFRct technology following coronary computed tomography angiograms for members with stable chest pain. The new positive decisions affect a total of 43 million individuals covered by the 3 companies, joining over 28.5 million individuals already covered by...
Source: Mass Device - August 31, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular HeartFlow Source Type: news

FDA clears Danaher ’ s Leica Microsystem ’ s FL560 cerebrovascular fluorescence microscope filter
Danaher‘s (NYSE:DHR) Leica Microsystems said yesterday it won FDA 510(k) clearance for its FL560 fluorescence microscope filter designed for visualizing cerebrovascular blood flow when used in conjunction with dye fluorescein. The filter is designed to be integrated into a M530 OH6 neurosurgical microscope to provide real-time, high-contrast visualization of cerebral anatomy in native color and fluorescent blood flow, the Germany-based company said. Leica said that the integration of the filter allows for a high-contrast image with clearly visible anatomy, with even the smallest vessels delineated. “Leica Micro...
Source: Mass Device - August 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: 510(k) Business/Financial News Imaging Neurological Regulatory/Compliance Danaher Corp. leicamicrosystems Source Type: news

Coronary artery disease in patients undergoing coronary angiography
(Bentham Science Publishers) Historically, from the 1930s to the 1950s, the rate of cardiovascular disease in high-income countries was high. Since the mid-1970s, the rate of cardiovascular disease has declined in high income countries, possibly due to socioeconomic inequalities and better management of risk factors for coronary heart disease among the wealthy. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - August 17, 2017 Category: International Medicine & Public Health Source Type: news

Osceola Regional Medical Center gives 1st look at $50M expansion
The Osceola Regional Medical Center on Aug. 16 gave Orlando Business Journal an inside look at the projects in its undergoing $50 million expansion, which is set to be completed this year. Due to the expansion, the hospital will increase the number of its beds from 332 to 404. The $50 expansion and renovations Include: A new comprehensive stroke center: This will be the only advanced comprehensive stroke center in the county. The hospital has a biplane angiography system that prod uces detailed… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 16, 2017 Category: American Health Authors: Veronica Brezina Source Type: news

PET Dominates in Non-invasive CAD Detection Accuracy (CME/CE)
(MedPage Today) -- But noninferiority found overall among PET, CT angiography, and SPECT (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 16, 2017 Category: Cardiology Source Type: news

Same-Session Angiography, Ad Hoc PCI Feasible for Select TAVRs Same-Session Angiography, Ad Hoc PCI Feasible for Select TAVRs
The strategy, potentially more efficient and less costly than staged procedures, was also safe in the single-center study; observers point to possible advantages and pitfalls.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 15, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Siemens inks tech supply, R & D deal with Houston Methodist Hospital
Siemens (NYSE:SI) Healthineers said today it inked a multi-year deal with Houston Methodist Hospital to integrate its imaging technologies into the Houston Methodist’s facilities and engage in joint research & development Through the deal, the Houston Methodist Research Institute will be equipped with Siemens devices and platforms for angiography, magnetic resonance imaging, computed tomography, molecular imaging, imaging IT and ultrasound. “We are eager to start our work together and look forward to seeing the outcome of this promising collaboration. We also look forward to working with scientists at ...
Source: Mass Device - August 15, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Hospital Care Research & Development Siemens Source Type: news

HeartFlow touts 4 positive BCBS policy decisions for its FFRct tech
HeartFlow said today it won positive medical policy decisions from 4 different Blue Cross Blue Shield groups across the US for its HeartFlow FFRct fractional flow reserve technology. The Redwood City, Calif.-based company said that Horizon BCBS of New Jersey, BCBS of Arizona, BCBS of Idaho and BCBS of Kansas City issued determinations supporting the use of the company’s noninvasive FFRct, following a positive coronary computed tomography angiogram, for patients with stable chest pain. “These new coverage decisions add to the growing number of payers that have reviewed evidence from clinical trials demonstr...
Source: Mass Device - August 8, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Business/Financial News Cardiovascular HeartFlow Source Type: news

LimFlow touts pDVA pilot trial data, technical success rate
LimFlow today released results from the pilot study of its LimFlow percutaneous deep vein arterialization system, touting that the trial met all its safety endpoints and had a technical success rate of 100%. The French company’s pDVA system is designed to restore perfusion to ischemic feet to relieve resting pain, promote chronic wound healing, reduce amputations and restore mobility. The system uses ultrasound-guided catheters and covered nitinol stents to bypass diseased arteries and divert blood flow to the tibial vein to vascularize the affected feet. “PDVA is an innovative approach for treating no-opt...
Source: Mass Device - August 1, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Diabetes LimFlow Source Type: news

CORE320: CTA and MPI for Noninvasive Assessment of CAD CORE320: CTA and MPI for Noninvasive Assessment of CAD
CT angiography and CT myocardial perfusion imaging showed as much prognostic utility in individuals with suspected coronary artery disease as did conventional angiography and SPECT imaging.Medscape Radiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 28, 2017 Category: Consumer Health News Tags: Radiology Viewpoint Source Type: news

Improving Endovascular Tx Access Is Not Simple
(MedPage Today) -- Distribution of specialists, angiography suites remains a hot-button issue (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - July 27, 2017 Category: American Health Source Type: news

Scoring System for Coronary CT Angiography Validated Scoring System for Coronary CT Angiography Validated
New findings show use of CAD-RADS to standardize coronary CT angiography reporting in patients with suspected angina due to CHD works well and is'ready for clinical use,'researchers say.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 19, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Toshiba touts money savings with CT for stroke care
Toshiba Medical is highlighting the money savings realized by one of its customer...Read more on AuntMinnie.comRelated Reading: Toshiba, AHRA open Putting Patients First grant program CIVCO, Toshiba partner on ultrasound products Toshiba releases Pianissimo Zen at 1.5 tesla Toshiba releases upgrades to Celesteion PET/CT Toshiba debuts new angiography system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 19, 2017 Category: Radiology Source Type: news

QoL in Patients With Suspected Angina Undergoing CTCA QoL in Patients With Suspected Angina Undergoing CTCA
This study suggests that by clarifying diagnosis and directing appropriate treatment, CT coronary angiography in patients with suspected angina directly impacts their symptoms and quality of life.Heart (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 19, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Updated meta-analysis to compare the efficacy and safety of S-DAPT versus L-DAPT strategies
(Society for Cardiovascular Angiography and Interventions) Researchers have evaluated the long-term efficacy and safety of long duration dual anti-platelet therapy (L-DAPT) compared to short duration DAPT (S-DAPT) after drug-eluting stent (DES) implantation. The current meta-analysis is the first to compare outcomes between S-DAPT and L-DAPT in a meta-analysis restricted to trials with patient follow-up of 24 months or longer. The research is detailed in the Editor's Choice article of the July 2017 issue of Catheterization and Cardiovascular Interventions. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2017 Category: International Medicine & Public Health Source Type: news

HeartFlow wins AMA CPT codes for FFRct cardiac tech
HeartFlow said today it won a new set of category III Current Procedural Terminology codes from the American medical Association for its FFRct fractional flow reserve technology. The newly won CPT code application was submitted by the American College of Cardiology, the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Angiography and Interventions, the Redwood City, Calif.-based company said. HeartFlow said the new codes show that the company’s FFRct “is a unique and distinct analysis that provides important and actionable clinical information above and beyond that of a coronary ...
Source: Mass Device - July 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular HeartFlow Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 22, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. pSivida seeks European regulatory nod for Durasert pSivida is looking to market its Durasert 3-year treatment for posterior segment uveitis in the European Union. Today, the Watertown, Mass.-based company submitted a marketing ...
Source: Mass Device - June 22, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

TriReme Medical touts Chocolate Heart drug-coated balloon data
QT Vascular subsidiary TriReme Medical touted angiographic data today from a 24-month follow-up of patients treated with its Chocolate Heart drug-coated balloon. The Chocolate Heart device is a paclitaxel-coated version of the company’s Chocolate coronary balloon that is commercially available in the U.S. The combo therapy was designed to reduce the incidence of repeat procedures and minimize the need for a stent, according to TriReme. Get the full story at our sister site, Drug Delivery Business News. The post TriReme Medical touts Chocolate Heart drug-coated balloon data appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - June 22, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Cardiovascular Clinical Trials Drug-Device Combinations Pharmaceuticals QT Vascular TriReme Medical Inc. Source Type: news

Toshiba releases Pianissimo Zen at 1.5 tesla
Toshiba Medical is introducing a new 1.5-tesla version of its Vantage Titan...Read more on AuntMinnie.comRelated Reading: Toshiba releases upgrades to Celesteion PET/CT Toshiba debuts new angiography system SCCT names Toshiba Young Investigator finalists SCCT, Toshiba partner on radiology fellows program Report: Toshiba Medical to adopt Canon branding in 2018 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 22, 2017 Category: Radiology Source Type: news

HeartFlow wins BCBS reimbursement nod
HeartFlow said today it won a positive healthcare evidence review from Blue Cross Blue Shield’s Evidence Street for its HeartFlow FFRct technology. In the review, BCBS’s Evidence Street determined that the FFRct technology “provides a meaningful improvement in net health outcome when used to guide the care of patients with stable chest pain who are at immediate risk of CAD and are being considered for invasive coronary angiography,” according to an SEC filing.. “This marks a major milestone achievement for HeartFlow and our FFRct technology because BCBS’s Evidence Street is among th...
Source: Mass Device - June 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Cardiovascular HeartFlow Source Type: news

PROMISE: CCTA better than functional cardiac testing
Coronary CT angiography (CCTA) does a better job than functional cardiac testing...Read more on AuntMinnie.comRelated Reading: CCTA can cut complications and hospital stays Coronary CTA beats stress test for changing lifestyles New guidelines offer reporting standards for CCTA All the same? Costs vary little in coronary disease tests (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 13, 2017 Category: Radiology Source Type: news

CT angiography appears better at predicting future risk for patients with chest pain
(Massachusetts General Hospital) An analysis of diagnostic test results from a trial comparing anatomic with functional testing as an initial diagnostic strategy for patients with chest pain found that CT angiography better predicted the risk for future cardiac events than did measures of exercise tolerance or restricted blood flow to the heart muscle. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2017 Category: International Medicine & Public Health Source Type: news

Toshiba releases upgrades to Celesteion PET/CT
Toshiba Medical has released an upgraded version of its Celesteion PET/CT system.Read more on AuntMinnie.comRelated Reading: Toshiba debuts new angiography system Toshiba installs 1st Vantage Galan 3T MRI scanner Toshiba Medical deal helps boost Canon financial results ASRT, Toshiba take applications for Safety First grants Toshiba delivers 1st Infinix-i Sky+ system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - June 8, 2017 Category: Radiology Source Type: news

Vascular graft dev Somahlution launches EU registry trial of DuraGraft
Vascular graft developer Somahlution said today it launched the DuraGraft European Registry clinical trial of its DuraGraft device, enrolling the 1st patient in the study. In the registry study, investigators will evaluate the Jupiter, Fla.-based company’s DuraGraft, a vascular graft treatment designed to reduce the burden of ischemia reperfusion injuries, during use in coronary artery bypass grafting procedures. The 1st patient was enrolled at Germany’s Helios Hospital Wuppertal, with enrollment also beginning at the Helios Heart Center Leipzig. The 1st patient was treated by Dr. Herbert Vetter, Somahluti...
Source: Mass Device - May 30, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Stent Grafts Vascular somahlution Source Type: news

Toshiba debuts new angiography system
Toshiba America Medical Systems will showcase a new angiography system with...Read more on AuntMinnie.comRelated Reading: SCCT names Toshiba Young Investigator finalists Imaging companies react to WannaCry threat in U.S. Toshiba installs 1st Vantage Galan 3T MRI scanner Toshiba Medical deal helps boost Canon financial results Toshiba delivers 1st Infinix-i Sky+ system (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 30, 2017 Category: Radiology Source Type: news

Neural Analytics touts 95% accuracy for TCD platform in Expedite trial
Neural Analytics today released initial results from the Expedite study of its Transcranial Doppler Tech platform, touting 95% accuracy in the early detection of acute ischemic stroke due to large vessel occlusion. Data from the study was presented at the 26th annual European Stroke Conference this week in Berlin. The 45-subject trial examined the use of TCD scans in patients experiencing computer tomography angiography confirmed acute ischemic stroke due to large vessel occlusion of the internal carotid artery or middle cerebral artery. Scans with the TCD platform were analyzed with 2 different stroke assessment algo...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Diagnostics Neurological Ultrasound Neural Analytics Source Type: news

Treat the Patient, Not the Angiogram Treat the Patient, Not the Angiogram
Should patients with refractory angina and coronary chronic total occlusion be offered the option of revascularization?Circulation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 22, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

7 medtech stories we missed this week: May 19, 2017
[Image from unsplash.com]From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The sterile-packaged wireless disposable device uses miniature sensors and actuators to balance knee joints during full-range motions. Using constant pressure bellows systems, the device communicates with a display for multiaxial balance and selection of th...
Source: Mass Device - May 19, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Research & Development Body Vision Medical Exactech Inc. Lombard Medical Technologies MedTech NxThera Inc. Rivanna Medical Visionsense XpandOrtho Source Type: news

Transradial Access May Mitigate Acute Kidney Injury in ACS Transradial Access May Mitigate Acute Kidney Injury in ACS
Data from a MATRIX substudy support a radial-first approach for ACS patients undergoing angiography or PCI, but operator expertise remains a critical part of the equation.Heartwire from Medscape (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 19, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Intravascular Ultrasound Guidance Improves Left Main Coronary Artery Stenting Intravascular Ultrasound Guidance Improves Left Main Coronary Artery Stenting
The outcomes of unprotected left main coronary artery (LMCA) stenting were better with intravascular ultrasound (IVUS) guidance than with angiography guidance alone, in a nationwide observational study from Sweden.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 17, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Analyze This Image: Acute Chest Pain: What's Up? Analyze This Image: Acute Chest Pain: What's Up?
Can you guess what the angiogram will show based on the patient presentation and the initial echo findings?theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 17, 2017 Category: Consumer Health News Tags: Cardiology Clinical Case Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 16, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Corindus touts high success rate in CorPath 200 PCI registry study Corindus Vascular Robotics today released post-market findings from the Precision registry study of its CorPath 200 system used during percutaneous coronary int...
Source: Mass Device - May 16, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Corindus touts high success rate in CorPath 200 PCI registry study
Corindus Vascular Robotics (NYSE:CVRS) released post-market findings from the Precision registry study of its CorPath 200 system used during percutaneous coronary interventions, touting high clinical and technical success rates. Data from the registry study was presented at the 2017 Society for Cardiovascular Angiography and Interventions Scientific Sessions last Friday, the Waltham, Mass.-based company said. The Precision post-market registry study aimed to explore the effectiveness of the Corindus’ CorPath 200 system during routine use in PCI procedures. The study examined the use of the device in 754 patients...
Source: Mass Device - May 16, 2017 Category: Medical Devices Authors: Fink Densford Tags: Catheters Clinical Trials Robot-Assisted Surgery Robotics Surgical Corindus Vascular Robotics Source Type: news

Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions
Read clinically focused news coverage of key developments from SCAI 2017theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 12, 2017 Category: Consumer Health News Tags: Conference Coverage Source Type: news

Race, gender and socioeconomic factors impact PCI outcomes
(Society for Cardiovascular Angiography and Interventions) Results from 'Interaction Effects of Race/Ethnicity and Sex on Outcomes after PCI: A Subanalysis of the PLATINUM Diversity study' were presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2017 Category: International Medicine & Public Health Source Type: news

Analysis looks at role type of valve plays in patient outcomes post-TAVR
(Society for Cardiovascular Angiography and Interventions) Results from 'Impact of valve design and bivalirudin vs. unfractionated heparin for anticoagulation in transcatheter aortic valve replacement: Results from the BRAVO-3 trial' were presented today as a late-breaking clinical trial at the Society for CardiovascularAngiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2017 Category: International Medicine & Public Health Source Type: news

SCAI honors members for outstanding service, dedication
(Society for Cardiovascular Angiography and Interventions) Awards presented today at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Session in New Orleans recognize outstanding SCAI members for their ongoing contributions to the field of interventional cardiology, the Society and patient care. Honorees span a broad spectrum of practitioners, all of whom have demonstrated a commitment to excellence throughout their careers, helping to shape the Society as well as the lives of patients and mentees. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 12, 2017 Category: International Medicine & Public Health Source Type: news

Analysis shows increased risk of early stroke with new-onset atrial fibrillation post-TAVR
(Society for Cardiovascular Angiography and Interventions) Results from 'Effect of bivalirudin versus unfractionated heparin in patients with baseline or new-onset atrial fibrillation in transcatheter aortic valve replacement: From the BRAVO-3 randomized trial' were presented today as a late-breaking clinical trial at the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - May 11, 2017 Category: International Medicine & Public Health Source Type: news

Twelve rising interventional cardiologists selected for Emerging Leader Mentorship Program
(Society for Cardiovascular Angiography and Interventions) The Society for Cardiovascular Angiography and Interventions (SCAI) is pleased to announce the selection of 12 early-career interventional cardiologists to participate in the 2017-19 Emerging Leader Mentorship (ELM) Program. These promising young physicians will take part in an intense, hands-on, two-year mentorship program to improve and refine their skills as leaders in medicine, ambassadors for their specialty and advocates for their patients. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 10, 2017 Category: International Medicine & Public Health Source Type: news

Lessening radiation risk for children with congenital and acquired heart disease
(Society for Cardiovascular Angiography and Interventions) Newly released recommendations for pediatric radiation safety will be discussed during the Society for Cardiovascular Angiography and Interventions (SCAI) 2017 Scientific Sessions in New Orleans. Leading experts will discuss these recommendations during theImage Gently Campaign: Radiation Safety in Pediatric Catheterization session, Wednesday, May 10, 3:00 p.m.CDT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 9, 2017 Category: International Medicine & Public Health Source Type: news

Invasive Approach to Unstable Angina May Cut Mortality Risk Invasive Approach to Unstable Angina May Cut Mortality Risk
Invasive coronary angiography up to two months after hospitalization for unstable angina might prevent 5% of deaths, researchers in Australia suggest.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 4, 2017 Category: Radiology Tags: Internal Medicine News Source Type: news

GE Healthcare wins FDA nod for Visipaque coronary CT angiography injection
GE Healthcare (NYSE:GE) said today that it won an indication approval from the FDA for its Visipaque injection imaging agent. The 320 milligram iodine per milliliter injection is an iso-osmolar agent that the federal watchdog approved for use in coronary computed tomography angiography. The new indication allows doctors to image coronary arteries of patients to help diagnose coronary artery disease using a non-invasive technique. Traditionally, healthcare practitioners use invasive coronary angiography procedures to diagnose coronary artery disease. Get the full story at our sister site, Drug Delivery Business News. T...
Source: Mass Device - May 2, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: Cardiovascular Diagnostics Drug-Device Combinations Food & Drug Administration (FDA) Regulatory/Compliance Wall Street Beat Source Type: news

Early Coronary Angiography Tied to Lower Mortality Risk in Unstable Angina (FREE)
By Kelly Young Edited by David G. Fairchild, MD, MPH, and Jaye Elizabeth Hefner, MD Coronary angiography is associated with reduced mortality risk in patients admitted with unstable angina, according to a retrospective study in the Annals of Internal Medicine. (Guidelines from … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - May 2, 2017 Category: Primary Care Source Type: news

Fewer Deaths With Routine Catheterization for Unstable Angina? (CME/CE)
(MedPage Today) -- Large study observes 2-month window for invasive angiography benefit (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 1, 2017 Category: Cardiology Source Type: news

Less-Aggressive Approach to Non-ST Segment Elevation ACS Advised Less-Aggressive Approach to Non-ST Segment Elevation ACS Advised
Holding off on coronary angiography for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and elevated cardiac troponin T is not associated with higher long-term risks of death or myocardial infarction (MI).Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - May 1, 2017 Category: Radiology Tags: Emergency Medicine News Source Type: news